Who
Michael E. Prevoznik
SVP & General Counsel
Company insider
Files Form 4 as: SVP & General Counsel, Quest Diagnostics.
In numbers
- Trades disclosed
- 307
- Buys
- 0
- Sells
- 76
- Bought
- $0
- Sold
- $106.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Feb 2006
- Last trade
- 28 Aug 2026
- Last filed
- 31 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code M | $2.5M22,677 at $112.17 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $3.9M16,010 at $242.88 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M6,237 at $243.63 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $2.5M22,677 at $112.17 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $105K430 at $244.51 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $2.5M22,677 at $112.17 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code M | $2.5M22,677 at $112.17 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $3.9M16,010 at $242.88 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M6,237 at $243.63 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $105K430 at $244.51 | filing |
| 28 Aug 2026filed 31 Aug 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $800K3,878 at $206.21 | filing |
| 5 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $800K3,878 at $206.21 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.5M7,232 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $687K3,354 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.5M7,232 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $687K3,354 at $204.86 | filing |
| 3 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $109K526 at $207.73 | filing |
| 3 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $109K526 at $207.73 | filing |
News
Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.13 EPSDGX · themarketsdaily.com · 22 Oct 2026Quest Diagnostics (NYSE: DGX) lifts guidance after revenue jumps 10%DGX · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Michael E. Prevoznik; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.